Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MSCI Inc.MSCI · Entity 3075 | Director · Chairman and CEO | May 15, 2026 | May 18, 2026 |
| Royalty Pharma plcRPRX · Entity 3100 | Director | June 30, 2025 | June 30, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MSCI Inc.
Report date May 15, 2026 · Filed May 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,731,961 |
Ending reported balance
After 2026-05-15 transaction · row 7
7 source rows · reconciled sequenceRow 1 · 2026-05-15 · Purchase · Acquired 120 · Balance 1,728,081 F1: This transaction was executed in multiple trades at prices ranging from $558.85 to $559.83. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Row 2 · 2026-05-15 · Purchase · Acquired 240 · Balance 1,728,321 F2: This transaction was executed in multiple trades at prices ranging from $559.90 to $560.75. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Row 3 · 2026-05-15 · Purchase · Acquired 1,238 · Balance 1,729,559 F3: This transaction was executed in multiple trades at prices ranging from $560.91 to $561.88. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Row 4 · 2026-05-15 · Purchase · Acquired 1,122 · Balance 1,730,681 F4: This transaction was executed in multiple trades at prices ranging from $562.01 to $562.96. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Row 5 · 2026-05-15 · Purchase · Acquired 800 · Balance 1,731,481 F5: This transaction was executed in multiple trades at prices ranging from $563.03 to $563.90. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Row 6 · 2026-05-15 · Purchase · Acquired 400 · Balance 1,731,881 F6: This transaction was executed in multiple trades at prices ranging from $564.12 to $564.74. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Row 7 · 2026-05-15 · Purchase · Acquired 80 · Balance 1,731,961 F7: This transaction was executed in multiple trades at prices ranging from $565.16 to $565.17. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. |
| Common StockSEC Table I · non-derivative | IndirectBy Fernandez 2007 Children's Trust | 410,776 |
Reported balance
Holding disclosure · report date 2026-05-15 · row 8
Holding and transaction disclosures are not merged.
1 source rowRow 8 · Balance 410,776 |
| Common StockSEC Table I · non-derivative | IndirectBy Son | 15,400 |
Reported balance
Holding disclosure · report date 2026-05-15 · row 9
Holding and transaction disclosures are not merged.
1 source rowRow 9 · Balance 15,400 |
| Common StockSEC Table I · non-derivative | IndirectBy Son | 15,400 |
Reported balance
Holding disclosure · report date 2026-05-15 · row 10
Holding and transaction disclosures are not merged.
1 source rowRow 10 · Balance 15,400 |
| Common StockSEC Table I · non-derivative | IndirectBy Daughter | 15,400 |
Reported balance
Holding disclosure · report date 2026-05-15 · row 11
Holding and transaction disclosures are not merged.
1 source rowRow 11 · Balance 15,400 |
| Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $549.83 · Expires 2032-02-03 | Direct | 29,564 |
Reported balance
Holding disclosure · report date 2026-05-15 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 29,564 |
| Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $554.52 · Expires 2033-02-02 | Direct | 42,193 |
Reported balance
Holding disclosure · report date 2026-05-15 · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · Balance 42,193 |
| Premium option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1,000.00 · Expires 2035-01-31 | Direct | 36,846 |
Reported balance
Holding disclosure · report date 2026-05-15 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 36,846 |
| Premium option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1,100.00 · Expires 2035-01-31 | Direct | 40,780 |
Reported balance
Holding disclosure · report date 2026-05-15 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 40,780 |
| Premium option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1,200.00 · Expires 2035-01-31 | Direct | 44,920 |
Reported balance
Holding disclosure · report date 2026-05-15 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 44,920 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $558.85 to $559.83. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected.
F2: This transaction was executed in multiple trades at prices ranging from $559.90 to $560.75. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $560.91 to $561.88. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected.
F4: This transaction was executed in multiple trades at prices ranging from $562.01 to $562.96. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected.
F5: This transaction was executed in multiple trades at prices ranging from $563.03 to $563.90. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected.
F6: This transaction was executed in multiple trades at prices ranging from $564.12 to $564.74. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected.
F7: This transaction was executed in multiple trades at prices ranging from $565.16 to $565.17. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected.
Royalty Pharma plc
Report date June 30, 2025 · Filed June 30, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Ordinary SharesSEC Table I · non-derivative | Direct | 65,324 |
Reported balance
After 2025-06-30 transaction · row 1
1 source rowRow 1 · 2025-06-30 · Grant · Acquired 1,064 · Balance 65,324 F1: Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500. |
| Class A Ordinary SharesSEC Table I · non-derivative | IndirectBy Fernandez 2007 Children's Trust | 58,200 |
Reported balance
Holding disclosure · report date 2025-06-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 58,200 |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2026 Filed May 18, 2026 16:10 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 80 | $565.17 | $45,213.60 |
DisclosureSEC source: 0001416750-26-000011 · wk-form4_1779135010.xml · nonDerivative · entry 7 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,731,961 F7 · price: This transaction was executed in multiple trades at prices ranging from $565.16 to $565.17. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| May 15, 2026 Filed May 18, 2026 16:10 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 400 | $564.42 | $225,768.00 |
DisclosureSEC source: 0001416750-26-000011 · wk-form4_1779135010.xml · nonDerivative · entry 6 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,731,881 F6 · price: This transaction was executed in multiple trades at prices ranging from $564.12 to $564.74. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| May 15, 2026 Filed May 18, 2026 16:10 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 800 | $563.39 | $450,712.00 |
DisclosureSEC source: 0001416750-26-000011 · wk-form4_1779135010.xml · nonDerivative · entry 5 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,731,481 F5 · price: This transaction was executed in multiple trades at prices ranging from $563.03 to $563.90. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| May 15, 2026 Filed May 18, 2026 16:10 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 1,122 | $562.47 | $631,091.34 |
DisclosureSEC source: 0001416750-26-000011 · wk-form4_1779135010.xml · nonDerivative · entry 4 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,730,681 F4 · price: This transaction was executed in multiple trades at prices ranging from $562.01 to $562.96. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| May 15, 2026 Filed May 18, 2026 16:10 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 1,238 | $561.56 | $695,211.28 |
DisclosureSEC source: 0001416750-26-000011 · wk-form4_1779135010.xml · nonDerivative · entry 3 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,729,559 F3 · price: This transaction was executed in multiple trades at prices ranging from $560.91 to $561.88. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| May 15, 2026 Filed May 18, 2026 16:10 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 240 | $560.28 | $134,467.20 |
DisclosureSEC source: 0001416750-26-000011 · wk-form4_1779135010.xml · nonDerivative · entry 2 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,728,321 F2 · price: This transaction was executed in multiple trades at prices ranging from $559.90 to $560.75. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| May 15, 2026 Filed May 18, 2026 16:10 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 120 | $559.40 | $67,128.00 |
DisclosureSEC source: 0001416750-26-000011 · wk-form4_1779135010.xml · nonDerivative · entry 1 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,728,081 F1 · price: This transaction was executed in multiple trades at prices ranging from $558.85 to $559.83. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| April 28, 2026 Filed Apr 30, 2026 16:05 UTC | MSCI Inc. MSCI · Entity 3075 | GiftCommon Stock | 75,707 | $0.00 | $0.00 |
DisclosureSEC source: 0001416750-26-000009 · wk-form4_1777579518.xml · nonDerivative · entry 2 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fernandez 2007 Children's Trust Disclosed balance after: 410,776 F2 · balance_after: The reported transaction reflects the distribution of the remaining shares held by the 2024 GRAT to The Fernandez 2007 Children's Trust upon the scheduled termination of the 2024 GRAT. The spouse of the Reporting Person is the trustee of The Fernandez 2007 Children's Trust. Read SEC document |
| April 28, 2026 Filed Apr 30, 2026 16:05 UTC | MSCI Inc. MSCI · Entity 3075 | GiftCommon Stock | 75,707 | $0.00 | $0.00 |
DisclosureSEC source: 0001416750-26-000009 · wk-form4_1777579518.xml · nonDerivative · entry 1 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Henry Fernandez 2024 MSCI Annuity Trust Disclosed balance after: 0 F1 · balance_after: The balance shown reflects the transfer of 234,114 shares previously indirectly held by the Henry Fernandez 2024 MSCI Annuity Trust (the "2024 GRAT"), a grantor retained annuity trust established by the Reporting Person, to direct holdings of the Reporting Person, reflecting the final scheduled annuity payment from the 2024 GRAT. F2 · balance_after: The reported transaction reflects the distribution of the remaining shares held by the 2024 GRAT to The Fernandez 2007 Children's Trust upon the scheduled termination of the 2024 GRAT. The spouse of the Reporting Person is the trustee of The Fernandez 2007 Children's Trust. Read SEC document |
| February 17, 2026 Filed Feb 17, 2026 18:02 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 200 | $520.00 | $104,000.00 |
DisclosureSEC source: 0001416750-26-000006 · wk-form4_1771369363.xml · nonDerivative · entry 4 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,493,847 Read SEC document |
| February 17, 2026 Filed Feb 17, 2026 18:02 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 360 | $519.45 | $187,002.00 |
DisclosureSEC source: 0001416750-26-000006 · wk-form4_1771369363.xml · nonDerivative · entry 3 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,493,647 F3 · price: This transaction was executed in multiple trades at prices ranging from $518.97 to $519.89. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| February 17, 2026 Filed Feb 17, 2026 18:02 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 240 | $517.32 | $124,156.80 |
DisclosureSEC source: 0001416750-26-000006 · wk-form4_1771369363.xml · nonDerivative · entry 2 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,493,287 F2 · price: This transaction was executed in multiple trades at prices ranging from $516.77 to $517.67. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 18:02 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 6,000 | $524.18 | $3,145,080.00 |
DisclosureSEC source: 0001416750-26-000006 · wk-form4_1771369363.xml · nonDerivative · entry 1 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,493,047 F1 · price: This transaction was executed in multiple trades at prices ranging from $523.68 to $524.65. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 16:02 UTC | MSCI Inc. MSCI · Entity 3075 | GrantOption to purchase common stock · Derivative | 42,193 | $0.00 Strike: $554.52 | $0.00 |
DisclosureSEC source: 0001416750-26-000003 · wk-form4_1769634162.xml · derivative · entry 7 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,193 Underlying: Common Stock · 42,193 shares Expires 2033-02-02 F1 · shares: Represents the number of performance stock options ("PSOs") to purchase common stock earned by the reporting person following the certification by the Compensation, Talent and Culture Committee on January 26, 2026 of the achievement of the performance condition applicable to the PSOs. The PSOs were granted on February 2, 2023 and vest on the third anniversary of the grant date, subject to continuous service through such date and satisfaction of the performance condition for the performance period from January 1, 2023 and ending on December 31, 2025. The performance condition for the PSOs was met with respect to 42,193 shares of common stock, and the PSOs are scheduled to vest on February 2, 2026. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 06:38 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 40 | $541.90 | $21,676.00 |
DisclosureSEC source: 0001416750-25-000005 · wk-form4_1765280287.xml · nonDerivative · entry 19 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fernandez 2007 Children's Trust Disclosed balance after: 335,069 Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 06:38 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 240 | $540.37 | $129,688.80 |
DisclosureSEC source: 0001416750-25-000005 · wk-form4_1765280287.xml · nonDerivative · entry 18 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fernandez 2007 Children's Trust Disclosed balance after: 335,029 F17 · price: This transaction was executed in multiple trades at prices ranging from $540.05 to $540.46. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 06:38 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 114 | $539.35 | $61,485.90 |
DisclosureSEC source: 0001416750-25-000005 · wk-form4_1765280287.xml · nonDerivative · entry 17 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fernandez 2007 Children's Trust Disclosed balance after: 334,789 F16 · price: This transaction was executed in multiple trades at prices ranging from $538.95 to $539.66. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 06:38 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 80 | $537.75 | $43,020.00 |
DisclosureSEC source: 0001416750-25-000005 · wk-form4_1765280287.xml · nonDerivative · entry 16 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fernandez 2007 Children's Trust Disclosed balance after: 334,675 Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 06:38 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 317 | $536.90 | $170,197.30 |
DisclosureSEC source: 0001416750-25-000005 · wk-form4_1765280287.xml · nonDerivative · entry 15 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fernandez 2007 Children's Trust Disclosed balance after: 334,595 F15 · price: This transaction was executed in multiple trades at prices ranging from $536.75 to $537.15. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 06:38 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 552 | $536.02 | $295,883.04 |
DisclosureSEC source: 0001416750-25-000005 · wk-form4_1765280287.xml · nonDerivative · entry 14 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fernandez 2007 Children's Trust Disclosed balance after: 334,278 F14 · price: This transaction was executed in multiple trades at prices ranging from $535.67 to $536.59. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 06:38 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 547 | $535.10 | $292,699.70 |
DisclosureSEC source: 0001416750-25-000005 · wk-form4_1765280287.xml · nonDerivative · entry 13 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fernandez 2007 Children's Trust Disclosed balance after: 333,726 F13 · price: This transaction was executed in multiple trades at prices ranging from $534.59 to $535.58. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 06:38 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 260 | $533.22 | $138,637.20 |
DisclosureSEC source: 0001416750-25-000005 · wk-form4_1765280287.xml · nonDerivative · entry 12 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fernandez 2007 Children's Trust Disclosed balance after: 333,179 F12 · price: This transaction was executed in multiple trades at prices ranging from $533.12 to $533.26. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 06:38 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 140 | $532.37 | $74,531.80 |
DisclosureSEC source: 0001416750-25-000005 · wk-form4_1765280287.xml · nonDerivative · entry 11 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fernandez 2007 Children's Trust Disclosed balance after: 332,919 F11 · price: This transaction was executed in multiple trades at prices ranging from $531.79 to $532.60. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 06:38 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 80 | $541.23 | $43,298.40 |
DisclosureSEC source: 0001416750-25-000005 · wk-form4_1765280287.xml · nonDerivative · entry 10 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,487,047 Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 06:38 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 480 | $540.46 | $259,420.80 |
DisclosureSEC source: 0001416750-25-000005 · wk-form4_1765280287.xml · nonDerivative · entry 9 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,486,967 F10 · price: This transaction was executed in multiple trades at prices ranging from $540.35 to $540.50. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 06:38 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 1,106 | $539.57 | $596,764.42 |
DisclosureSEC source: 0001416750-25-000005 · wk-form4_1765280287.xml · nonDerivative · entry 8 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,486,487 F9 · price: This transaction was executed in multiple trades at prices ranging from $539.27 to $540.15. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 06:38 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 504 | $538.77 | $271,540.08 |
DisclosureSEC source: 0001416750-25-000005 · wk-form4_1765280287.xml · nonDerivative · entry 7 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,485,381 F8 · price: This transaction was executed in multiple trades at prices ranging from $538.16 to $538.97. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 06:38 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 431 | $537.31 | $231,580.61 |
DisclosureSEC source: 0001416750-25-000005 · wk-form4_1765280287.xml · nonDerivative · entry 6 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,484,877 F7 · price: This transaction was executed in multiple trades at prices ranging from $537.12 to $537.74. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 06:38 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 1,892 | $536.34 | $1,014,755.28 |
DisclosureSEC source: 0001416750-25-000005 · wk-form4_1765280287.xml · nonDerivative · entry 5 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,484,446 F6 · price: This transaction was executed in multiple trades at prices ranging from $536.00 to $536.97. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 06:38 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 3,190 | $535.51 | $1,708,276.90 |
DisclosureSEC source: 0001416750-25-000005 · wk-form4_1765280287.xml · nonDerivative · entry 4 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,482,554 F5 · price: This transaction was executed in multiple trades at prices ranging from $535.00 to $535.99. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 06:38 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 1,043 | $534.55 | $557,535.65 |
DisclosureSEC source: 0001416750-25-000005 · wk-form4_1765280287.xml · nonDerivative · entry 3 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,479,364 F4 · price: This transaction was executed in multiple trades at prices ranging from $534.00 to $534.86. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 06:38 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 1,124 | $533.12 | $599,226.88 |
DisclosureSEC source: 0001416750-25-000005 · wk-form4_1765280287.xml · nonDerivative · entry 2 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,478,321 F3 · price: This transaction was executed in multiple trades at prices ranging from $532.72 to $533.55. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 06:38 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 360 | $531.98 | $191,512.80 |
DisclosureSEC source: 0001416750-25-000005 · wk-form4_1765280287.xml · nonDerivative · entry 1 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,477,197 F1 · price: This transaction was executed in multiple trades at prices ranging from $531.57 to $532.56. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. F2 · balance_after: The balance shown reflects the transfer of 196,886 shares previously indirectly held by the Henry Fernandez 2024 MSCI Annuity Trust (the "2024 GRAT"), a grantor retained annuity trust established by the Reporting Person to direct holdings of the Reporting Person following a scheduled annuity payment from the 2024 GRAT. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 16:30 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 43 | $550.41 | $23,667.63 |
DisclosureSEC source: 0001408198-25-000181 · wk-form4_1753734612.xml · nonDerivative · entry 4 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,279,951 F2 · price: This transaction was executed in multiple trades at prices ranging from $550.00 to $550.97. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 16:30 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 18 | $547.49 | $9,854.82 |
DisclosureSEC source: 0001408198-25-000181 · wk-form4_1753734612.xml · nonDerivative · entry 3 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,279,908 Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 16:30 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 23 | $546.40 | $12,567.20 |
DisclosureSEC source: 0001408198-25-000181 · wk-form4_1753734612.xml · nonDerivative · entry 2 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,279,890 Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 16:30 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 2,400 | $535.11 | $1,284,264.00 |
DisclosureSEC source: 0001408198-25-000181 · wk-form4_1753734612.xml · nonDerivative · entry 5 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fernandez 2007 Children's Trust Disclosed balance after: 332,779 Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 16:30 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 9,916 | $544.70 | $5,401,245.20 |
DisclosureSEC source: 0001408198-25-000181 · wk-form4_1753734612.xml · nonDerivative · entry 1 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,279,867 F1 · price: This transaction was executed in multiple trades at prices ranging from $544.18 to $545.00. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| June 30, 2025 Filed Jun 30, 2025 21:06 UTC | Royalty Pharma plc RPRX · Entity 3100 | GrantClass A Ordinary Shares | 1,064 | $35.24 | $37,494.83 |
DisclosureSEC source: 0001802768-25-000077 · wk-form4_1751317557.xml · nonDerivative · entry 1 Fernandez Henry A · CIK 0001416750 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,324 F1 · price: Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500. Read SEC document |
| May 13, 2025 Filed May 14, 2025 21:08 UTC | Royalty Pharma plc RPRX · Entity 3100 | GrantClass A Ordinary Shares | 7,614 | $0.00 | $0.00 |
DisclosureSEC source: 0001802768-25-000051 · wk-form4_1747256918.xml · nonDerivative · entry 1 Fernandez Henry A · CIK 0001416750 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,260 F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 21:45 UTC | Royalty Pharma plc RPRX · Entity 3100 | GrantClass A Ordinary Shares | 1,141 | $32.87 | $37,499.88 |
DisclosureSEC source: 0001802768-25-000016 · wk-form4_1743543926.xml · nonDerivative · entry 1 Fernandez Henry A · CIK 0001416750 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,646 F1 · price: Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500. Read SEC document |
| February 24, 2025 Filed Feb 25, 2025 06:27 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 100 | $575.66 | $57,566.00 |
DisclosureSEC source: 0001408198-25-000066 · wk-form4_1740482855.xml · nonDerivative · entry 3 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,269,951 Read SEC document |
| February 24, 2025 Filed Feb 25, 2025 06:27 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 4,700 | $574.98 | $2,702,406.00 |
DisclosureSEC source: 0001408198-25-000066 · wk-form4_1740482855.xml · nonDerivative · entry 2 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,269,851 F2 · price: This transaction was executed in multiple trades at prices ranging from $574.645 to $575.61. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| February 24, 2025 Filed Feb 25, 2025 06:27 UTC | MSCI Inc. MSCI · Entity 3075 | PurchaseCommon Stock | 500 | $569.86 | $284,930.00 |
DisclosureSEC source: 0001408198-25-000066 · wk-form4_1740482855.xml · nonDerivative · entry 1 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,265,151 F1 · price: This transaction was executed in multiple trades at prices ranging from $569.82 to $570.00. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 16:01 UTC | MSCI Inc. MSCI · Entity 3075 | Tax withholdingCommon Stock | 32,279 | $587.48 | $18,963,266.92 |
DisclosureSEC source: 0001408198-25-000060 · wk-form4_1739221306.xml · nonDerivative · entry 2 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,264,651 F2 · shares: Represents shares reacquired by MSCI Inc. to satisfy tax withholding obligations in connection with the vesting and conversion to shares of 58,370 PSUs granted on February 6, 2020 (includes the performance adjustment as described above). Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 16:01 UTC | MSCI Inc. MSCI · Entity 3075 | GrantCommon Stock | 58,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001408198-25-000060 · wk-form4_1739221306.xml · nonDerivative · entry 1 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,296,930 F1 · shares: Represents the number of shares of common stock issued following the vesting and conversion of performance stock units ("PSUs") granted to the reporting person on February 6, 2020, upon certification by the Compensation, Talent and Culture Committee on February 6, 2025 of the achievement of the performance metric for the performance period from February 5, 2020 to February 4, 2025. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:01 UTC | MSCI Inc. MSCI · Entity 3075 | GrantPremium option to purchase common stock · Derivative | 44,920 | $0.00 Strike: $1,200.00 | $0.00 |
DisclosureSEC source: 0001408198-25-000036 · wk-form4_1738702896.xml · derivative · entry 3 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,920 Underlying: Common Stock · 44,920 shares Expires 2035-01-31 F1 · shares: Represents a grant of premium-priced stock options (PPOs) to purchase common stock that was granted on January 31, 2025 and vests on the fifth anniversary of the grant date, subject to continuous service through such date. The PPOs were granted in three tranches having exercise prices of $1,000 per share, $1,100 per share and $1,200 per share, respectively. For reference, the closing price of the Company's common stock on February 3, 2025, was $582.43. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:01 UTC | MSCI Inc. MSCI · Entity 3075 | GrantPremium option to purchase common stock · Derivative | 40,780 | $0.00 Strike: $1,100.00 | $0.00 |
DisclosureSEC source: 0001408198-25-000036 · wk-form4_1738702896.xml · derivative · entry 2 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,780 Underlying: Common Stock · 40,780 shares Expires 2035-01-31 F1 · shares: Represents a grant of premium-priced stock options (PPOs) to purchase common stock that was granted on January 31, 2025 and vests on the fifth anniversary of the grant date, subject to continuous service through such date. The PPOs were granted in three tranches having exercise prices of $1,000 per share, $1,100 per share and $1,200 per share, respectively. For reference, the closing price of the Company's common stock on February 3, 2025, was $582.43. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:01 UTC | MSCI Inc. MSCI · Entity 3075 | GrantPremium option to purchase common stock · Derivative | 36,846 | $0.00 Strike: $1,000.00 | $0.00 |
DisclosureSEC source: 0001408198-25-000036 · wk-form4_1738702896.xml · derivative · entry 1 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,846 Underlying: Common Stock · 36,846 shares Expires 2035-01-31 F1 · shares: Represents a grant of premium-priced stock options (PPOs) to purchase common stock that was granted on January 31, 2025 and vests on the fifth anniversary of the grant date, subject to continuous service through such date. The PPOs were granted in three tranches having exercise prices of $1,000 per share, $1,100 per share and $1,200 per share, respectively. For reference, the closing price of the Company's common stock on February 3, 2025, was $582.43. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 16:07 UTC | MSCI Inc. MSCI · Entity 3075 | GrantOption to purchase common stock · Derivative | 29,564 | $0.00 Strike: $549.83 | $0.00 |
DisclosureSEC source: 0001408198-25-000020 · wk-form4_1738184869.xml · derivative · entry 1 Fernandez Henry A · CIK 0001416750 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,564 Underlying: Common Stock · 29,564 shares Expires 2032-02-03 F1 · derivative.underlying_shares: Represents the number of performance stock options ("PSOs") to purchase common stock earned by the reporting person following the certification by the Compensation, Talent and Culture Committee on January 27, 2025 of the achievement of the performance condition applicable to the PSOs. The PSOs were granted on February 3, 2022 and vest on the third anniversary of the grant date, subject to continuous service through such date and satisfaction of the performance condition for the performance period from January 1, 2022 and ending on December 31, 2024. The performance condition for the PSOs was met with respect to 29,564 shares of common stock, and the PSOs are scheduled to vest on February 3, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.